Stay updated with breaking news from Alnylum pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Primary Hyperoxaluria Treatment MarketThe global primary hyperoxaluria treatments market is expected to develop at a compound annual growth rate (CAGR) of 8.6% between 2023 and 2033, according to a recent market research analysis by Future Market Insights. By the end of the forecast year previously indicated, the ma. ....
According to a new market research report published by Future Market Insights, the global Primary Hyperoxaluria Treatment Market is expected to grow at a CAGR of 8.6% during the forecast period of 2023 to 2033. The market is expected to surpass US$ 41 million in value terms by the end of the aforementioned forecast. ....